Thomas Caskey has been appointed as chair of the board of directors of Genome Canada. He has been a board member for several years and became vice-chair of the board last year.
Caskey is the director and CEO of the Brown Foundation Institute of Molecular Medicine and a professor at the Institute of Molecular Medicine at the University of Texas Health Sciences Center in Houston.
Previously, he was the managing director of Cogene Biotech Ventures and served as chairman of the department of molecular and human genetics at Baylor College of Medicine. He was also senior vice president of human genetics and vaccines discovery at Merck Research Laboratories and president of the Merck Genome Research Institute.
Caskey holds a medical doctorate from Duke University and an undergraduate degree from the University of South Carolina. He is board-certified in internal medicine, clinical genetics, metabolic diseases, and molecular diagnostics.
Bernard Sweeney has been appointed by the International Barcode of Life project to head its Freshwater Surveillance group, one of iBOL's 10 working groups. iBOL is assembling a DNA sequence library of the world's species using DNA barcode technology.
Sweeney is the director, president, and a senior research scientist of the Stroud Water Research Center in Avondale, Pa.
He holds a PhD in population biology and zoology from the University of Pennsylvania and a BS in biology from Delaware Valley College of Science and Agriculture.